Serogroup W-135 meningococcal disease during the Hajj, 2000 - Wikidata - wikimedia - TriplyDB

Serogroup W-135 meningococcal disease during the Hajj, 2000

Serogroup W-135 meningococcal disease during the Hajj, 2000

http://www.wikidata.org/entity/Q24290784

about

Neglected Tropical Diseases in the Anthropocene: The Cases of Zika, Ebola, and Other Infections Prospects for vaccine prevention of meningococcal infection Clinical features and outcome of sporadic serogroup W135 disease Taiwan.Importance of circulating antibodies in protection against meningococcal disease Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease Review of meningococcal vaccines with updates on immunization in adults Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy Potential for the international spread of middle East respiratory syndrome in association with mass gatherings in saudi arabia.Exploring culture: audience predispositions and consequent effects on audience behavior in a mass-gathering setting.Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice Emergence of W135 meningococcal meningitis in Ghana.Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.Use of a multilocus variable-number tandem repeat analysis method for molecular subtyping and phylogenetic analysis of Neisseria meningitidis isolates A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.Meningococcal disease and climate.Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study.Neisseria meningitidis: biology, microbiology, and epidemiology.Using single-nucleotide polymorphisms to discriminate disease-associated from carried genomes of Neisseria meningitidis.Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.Immunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b).The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiorit Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998-2004).Bacterial meningitis: the impact of vaccination.A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea.The changing epidemiology of meningococcal disease in North America 1945-2010.Spread of Neisseria meningitidis serogroup W clone, China A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine.Issues in pediatric vaccine-preventable diseases in low- to middle-income countries The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.Meningitis serogroup W135 outbreak, Burkina Faso, 2002 Outbreak of Neisseria meningitidis capsular group W among scouts returning from the World Scout Jamboree, Japan, 2015.Neisseria meningitidis serogroup W, Burkina Faso, 2012.Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign.Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™).Evolving meningococcal immunization strategies.Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience.Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence.Safety and immunogenicity of a meningococcal quadrivalent conjugate vaccine in five- to eight-year-old Saudi Arabian children previously vaccinated with two doses of a meningococcal quadrivalent polysaccharide vaccine.

P2860

Q24261182-75e2687b-48e6-80d1-9034-c744c2f5cceb Q24537338-E01CA7C3-5A31-47D7-B03C-6BC51D03B903 Q25257271-92B14248-A2D6-4DAE-BC9D-327D3E6F5606 Q27023516-FAE19E52-B09F-474B-B925-343171E94A65 Q27028161-7F91791F-04EE-41E3-8DFA-0A9405487218 Q28828692-733F43EC-278D-4714-AA44-77E38660DC74 Q28972389-639EB219-F1FB-4EE3-8B9E-5B08F739F69B Q30222093-06F7305C-A51A-446D-B148-66F79409EFAF Q30428402-1B529774-3151-4532-857D-511CB7639D95 Q30802758-18A7DA4E-CC86-44F0-B9D4-E812FAFDCC2E Q33229682-2392D220-96DA-4990-9DD4-54D6816E143A Q33233902-93AFF8CE-D88F-48A3-B8F8-6ABE7518C88D Q33243005-CE90388E-B0FA-4E55-8CD3-3343AAB0775B Q33334377-42533842-F0DE-45A7-86ED-795C6E907CB8 Q33561983-69326C89-E112-4F47-9FCF-0BFCD0A80A16 Q34627685-3594F7E3-F97B-4E49-B8DB-63588B4DD2CA Q34632986-F5FF277F-D604-46C2-AEFF-5714B208E8E2 Q35096463-4DFFF81F-1B36-4A03-BEA0-6EFE8646568C Q35542416-B693230A-A939-41D5-80C0-C7EEA9C9C406 Q35799561-F4DDBF62-9CDD-439E-9D0C-6F7F84AE58E7 Q36182445-98C720EA-7B5B-48BE-A001-E60208F2B137 Q36391883-3FC99B80-DAA6-42AA-A7C4-52A526942275 Q36778776-600B7AEA-7CBA-40C1-A923-4016CBD3AD06 Q36797196-2275AC7B-2598-46B5-A481-A673E82A7C95 Q36809117-880A40C5-1A1D-4437-B100-B4447BEEEB6D Q36887966-4953EB86-6039-471D-A70C-535E30830492 Q37262383-1F0037B9-F8FE-497E-BF8C-0F540BC49319 Q37263960-A2634BEB-946A-4C4E-B75B-6957C953DD8F Q37264972-01B5AB5E-9410-4935-BBA1-E91837D6AE33 Q37418853-2B3D7FDE-1633-47DB-AD11-E236698749FA Q37473705-EB3EDC76-D3B5-4789-B866-900D7E30B06C Q37485432-1321157E-735E-4490-A22E-DA1FD929DD9D Q37621672-081296DE-C5FC-49BC-857C-E4D61B0D413C Q37764910-3CEB59A9-A7FA-4397-86ED-248B17306D9A Q38066532-46F25EA6-088B-4F82-BA77-510C5213B203 Q38286082-0D4B77D9-206F-45FD-971E-FADE63373394 Q38298541-EA734F28-70E1-4FDB-857C-4A2E9C763947 Q38367830-0255448F-F209-4938-8FD8-154E056FC002 Q38743826-E75C3887-4571-477D-8410-016A5648AFCF Q41589390-494B1097-07D7-4B77-A266-070FB5B777F6

P2860

Serogroup W-135 meningococcal disease during the Hajj, 2000

http://www.wikidata.org/entity/Q24290784

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Serogroup W-135 meningococcal disease during the Hajj, 2000

@ast

Serogroup W-135 meningococcal disease during the Hajj, 2000

@en

Serogroup W-135 meningococcal disease during the Hajj, 2000

@en-gb

Serogroup W-135 meningococcal disease during the Hajj, 2000

@nl

type

label

Serogroup W-135 meningococcal disease during the Hajj, 2000

@ast

Serogroup W-135 meningococcal disease during the Hajj, 2000

@en

Serogroup W-135 meningococcal disease during the Hajj, 2000

@en-gb

Serogroup W-135 meningococcal disease during the Hajj, 2000

@nl

prefLabel

Serogroup W-135 meningococcal disease during the Hajj, 2000

@ast

Serogroup W-135 meningococcal disease during the Hajj, 2000

@en

Serogroup W-135 meningococcal disease during the Hajj, 2000

@en-gb

Serogroup W-135 meningococcal disease during the Hajj, 2000

@nl

P1433

Q24290784-363EDD91-F696-4C7B-8147-145849EDFA18

P1476

Q24290784-63E97EE4-D453-4DE3-99B4-5F7CCFA46212

P2093

Q24290784-23540F2F-C31E-468F-A367-D66EAB10D988

Q24290784-2EE2E229-08E0-4347-86EC-381B920B089A

Q24290784-4FA737E9-DAA4-4754-8C48-1178E59C037D

Q24290784-4FC6E5A1-AA7E-4108-BA4D-721D7AEFE5BF

Q24290784-5BDBFB37-A439-4812-8836-7C360CDAD1CA

Q24290784-681B4AAB-5FC5-4065-96D8-8D051A2E84C0

Q24290784-6C5BA572-754F-469E-84D9-327BE4A641E5

Q24290784-7484171A-1ACC-4637-BC84-E4C5A16722C2

Q24290784-79A38524-F006-4544-A42C-2182E27A9A6C

Q24290784-90AC5AAF-5F87-47BC-96D4-F20CD461CE9E

P2860

Q24290784-1544F76A-3571-44D4-93F5-5AC1CEF82CB7

Q24290784-1BFD6CD8-1F79-4F3B-8A35-F615250C0F65

Q24290784-1D86C3C0-FB37-4990-9BCE-4376B349639E

Q24290784-22F8A85F-F8DE-4A84-B6DA-68A7043AAF05

Q24290784-2D0A149E-795F-45BB-B318-4A28B14128E1

Q24290784-3230F9B8-A084-4F54-95BF-D38884E6149E

Q24290784-45BF9480-6441-4708-BFF0-6E2C0D305CA3

Q24290784-497CBA22-5958-4081-8849-4806B1225D5C

Q24290784-6474FACF-1125-454F-9759-680456BA36D7

Q24290784-871A212F-EADD-4CBD-B82D-EE54D4B67616

P304

Q24290784-C5B40BBE-463B-4BB2-ACE7-8E9D2B53DDD3

P31

Q24290784-5A53A6C8-F86C-4258-84B3-0C559CEBB90F

P3181

Q24290784-E2C0CA89-6D0A-4455-B7E7-3DA3436DC813

P356

Q24290784-EA6391DA-6671-4F56-8403-89D7A7A10E8A

P407

Q24290784-1DD478F0-749E-4A42-8C61-C1320C2FD605

P433

Q24290784-7BA734D2-30CA-40EA-AE3B-3357BD9D51B5

P478

Q24290784-C8DED348-D7EC-4561-AD33-AA267EB53FDB

P50

Q24290784-428e3328-45ad-16f9-5396-424baec1ab6d

P577

Q24290784-B611CECD-8CF2-4B48-B947-7DC5ED8710CE

P5875

Q24290784-B1A4BB6C-C81E-4704-B66F-5B5B288BCDBB

P698

Q24290784-D6DD8BA4-D342-43ED-8C82-3B567DDC619C

P932

Q24290784-3F49FEA3-EAD5-4F33-9DF9-F39FE3BBCD35

P3181

P356

P1433

Emerging Infectious Diseases

P1476

Serogroup W-135 meningococcal disease during the Hajj, 2000

@en

P2093

Abdulhafiz Turkistani

http://www.w3.org/2001/XMLSchema#string

Abdullah M Al-Rabeah

http://www.w3.org/2001/XMLSchema#string

Adel Fatani

http://www.w3.org/2001/XMLSchema#string

Amira Badukhan

http://www.w3.org/2001/XMLSchema#string

Bradley A Perkins

http://www.w3.org/2001/XMLSchema#string

Jairam R Lingappa

http://www.w3.org/2001/XMLSchema#string

Leonard W Mayer

http://www.w3.org/2001/XMLSchema#string

Mohamed Al-Jeffri

http://www.w3.org/2001/XMLSchema#string

Nassen Al-Hamdan

http://www.w3.org/2001/XMLSchema#string

Rana Hajjeh

http://www.w3.org/2001/XMLSchema#string

P2860

CEREBROSPINAL MENINGITIS IN AFRICA

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis

Population genetics and molecular epidemiology of Neisseria meningitidis.

Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.

Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C.

Group A meningococcal carriage in travelers returning from Saudi Arabia.

Prevention of meningococcal disease by group C polysaccharide vaccine.

Meningococcal disease.

P304

665-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2417098

http://www.w3.org/2001/XMLSchema#string

P356

10.3201/EID0906.020565

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Nancy E. Messonnier

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10730512

http://www.w3.org/2001/XMLSchema#string

P698

12781005

http://www.w3.org/2001/XMLSchema#string

P932

3000138

http://www.w3.org/2001/XMLSchema#string